Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
OxyContin maker Purdue Pharma loses bid to delay opioid epidemic trial
Source: Reuters
BUSINESS NEWS MARCH 8, 2019 / 7:24 PM / UPDATED 28 MINUTES AGO
OxyContin maker Purdue Pharma loses bid to delay opioid epidemic trial
Nate Raymond
3 MIN READ
(Reuters) - OxyContin maker Purdue Pharma LP and two other drugmakers on Friday lost a bid to delay a landmark trial set for May in a lawsuit by Oklahoma’s attorney general accusing them of helping fuel an opioid abuse and overdose epidemic in the state.
Cleveland County District Judge Thad Balkman’s decision was a win for the state, even as one of its lawyers said that Purdue had “threatened” to file for bankruptcy rather than face the first trial to result from around 2,000 lawsuits nationally.
“This case needs to get to trial because people are dying every day,” Reggie Whitten, a lawyer for the state, said during a hearing in Norman, Oklahoma.
Reuters, citing people familiar with the matter, on Monday reported that Stamford, Connecticut-based Purdue, owned by members of the wealthy Sackler family, was exploring filing for Chapter 11 bankruptcy protection.
-snip-
OxyContin maker Purdue Pharma loses bid to delay opioid epidemic trial
Nate Raymond
3 MIN READ
(Reuters) - OxyContin maker Purdue Pharma LP and two other drugmakers on Friday lost a bid to delay a landmark trial set for May in a lawsuit by Oklahoma’s attorney general accusing them of helping fuel an opioid abuse and overdose epidemic in the state.
Cleveland County District Judge Thad Balkman’s decision was a win for the state, even as one of its lawyers said that Purdue had “threatened” to file for bankruptcy rather than face the first trial to result from around 2,000 lawsuits nationally.
“This case needs to get to trial because people are dying every day,” Reggie Whitten, a lawyer for the state, said during a hearing in Norman, Oklahoma.
Reuters, citing people familiar with the matter, on Monday reported that Stamford, Connecticut-based Purdue, owned by members of the wealthy Sackler family, was exploring filing for Chapter 11 bankruptcy protection.
-snip-
Read more: https://www.reuters.com/article/us-usa-opioids-litigation/oxycontin-maker-purdue-pharma-loses-bid-to-delay-opioid-epidemic-trial-idUSKBN1QQ00B
